Nanobiotix

6 clinical trials · Sponsor

Record	Firm	Date
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy (NCT03589339)	Nanobiotix	2019-01-16
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma (NCT02805894)	Nanobiotix	2017-11-15

Every clearance here is in the API, with alerts when new ones post.